FundingCommerce & Consumer Brands
Be Clinical raises Rs 6 crore in extended seed
By Abha Lohia · Editor ·
Be Clinical: funding and every story →
extended seedFounded 2024
- Be Clinical is an evidence-led skincare brand offering clinically tested solutions for ageing skin, focusing on face, body, and scalp
- The company raised Rs 6 crore in an extended seed round led by V3 Ventures, with participation from Titan Capital
- Funds will boost R&D, in-house formulation, and manufacturing expansion, targeting India's gap in science-led anti-ageing products
What happened
- Be Clinical raised Rs 6 crore in an extended seed round led by V3 Ventures.
- Titan Capital, founded by Kunal Bahl and Rohit Bansal, participated in this tranche.
- The round's earlier tranche of Rs 2 crore was led by Titan Capital, with Aditya Agarwal of P-TAL also investing.
- Founder Hemangi Dhir launched the brand in May 2024.
- The company will use the funds for R&D, in-house formulation, and clinical testing.
- Plans include expanding the manufacturing facility with advanced machinery.
- The company will also upgrade packaging to functional, protective, and premium formats.
- Be Clinical has served over 25,000 customers since inception.
Why it matters
- The brand addresses a market gap: a lack of science-led, transparent, clinically validated skincare solutions for Indian skin.
- Its differentiation lies in in-vivo tested and clinically validated formulations, with end-to-end in-house research and manufacturing.
- The funding signals growing investor interest in evidence-based beauty brands in India.
- Competitors include Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing segment.
The business
- Be Clinical is an evidence-led skincare brand focused on ageing concerns across face, body, and scalp.
- Products include Neck Repair Skin Tightening Night Cream, PlumpX Serum, FirmX Serum, Blemish Balance Serum, and SmoothX Hand Cream.
- Prices range from Rs 999 to Rs 2,998.
- The company offers free shipping on orders over Rs 100.
- Clinical trials are registered on the Clinical Trial Registry of India.
- Customer reviews mention visible improvement and suitability for sensitive skin.
- The brand operates with an end-to-end in-house research and manufacturing model.
The founders
- Launched Be Clinical in May 2024.
- Leads the brand's vision for clinically validated skincare solutions for Indian skin.
Who put in money
- V3 Ventures lead
- Titan Capital participant — Founded by Kunal Bahl and Rohit Bansal.
In numbers
Rs 6 croreAmount raised · 2026
Rs 2 crorePrevious tranche · 2026
25,000+Customers served · 2026
Rs 999 - Rs 2,998Product price range · 2026
Rs 100Free shipping threshold · 2026
What happens next
- Expand manufacturing facility with advanced machinery.
- Upgrade packaging to functional, protective, and premium formats.
- Continue R&D and clinical testing for targeted ageing solutions.
Earlier rounds
- 2026-01-07 · extended seed · Rs 6 crore · led by V3 Ventures
- 2026-01-07 · seed (previous tranche) · Rs 2 crore · led by Titan Capital
Up against
OlayNeutrogenaCliniqueDr. Sheth
Words to know
- extended seed
- An additional funding round for a startup, typically after an initial seed round, to support early growth.
- in-vivo
- Tested on living organisms, such as human skin, rather than in a lab dish.
- R&D
- Research and development, the work a company does to create new products or improve existing ones.
- clinical trial
- A scientific study to test how well a product works in people, often registered for transparency.
The numbers around it
Be Clinical has 2 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 22 August 2026 | seed | ₹21 Cr | Sauce |
Commerce & Consumer Brands in January 2026: 32 rounds with a disclosed amount, $292 million in all; the biggest was iD Fresh (₹1,300 Cr). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
LaunchBlinkit starts ambulance service in BengaluruBlinkit is a quick-commerce app that delivers groceries and household items in minutes, and also runs an emergency ambulance servicePartnershipAtomberg and Voltas sign AC compressor ventureAtomberg makes energy-saving home appliances and has an Airtech subsidiary meant to build components for room air conditionersFundingBoba Bhai raises $18 million Series BBoba Bhai is a Bengaluru quick-service chain selling bubble tea and Korean street food
Everything on Be Clinical → · All startup news on 7 January 2026 →
Is this Be Clinical? Get your “Featured on StopDown” badge →